Related Experiment Video
Updated: Apr 24, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
The Notch pathway inhibits TGFβ signaling in breast cancer through HEYL-mediated crosstalk
Liangfeng Han1, Adam Diehl1, Nguyen K Nguyen1
1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abstract:
Acquired resistance to TGFβ is a key step in the early stages of tumorigenesis. Mutations in TGFβ signaling components are rare, and little is known about the development of resistance in breast cancer. On the other hand, an activated Notch pathway is known to play a substantial role in promoting breast cancer development. Here, we present evidence of crosstalk between these two pathways through HEYL. HEYL, a basic helix-loop-helix transcription factor and a direct target of Notch signaling, is specifically overexpressed in breast cancer. HEYL represses TGFβ activity by binding to TGFβ-activated Smads. HeyL(-/-) mice have defective mammary gland development with fewer terminal end buds. On the other hand, HeyL transgenic mice show accelerated mammary gland epithelial proliferation and 24% of multiparous mice develop mammary gland cancer. Therefore, repression of TGFβ signaling by Notch acting through HEYL may promote initiation of breast cancer.
Insights
Notch signaling, through HEYL, represses Transforming Growth Factor beta (TGFβ) activity. This crosstalk in breast cancer may drive tumorigenesis by overcoming TGFβ-mediated growth inhibition, promoting tumor initiation.
Area of Science:
- Oncology
- Molecular Biology
- Developmental Biology
Background:
- Acquired resistance to Transforming Growth Factor beta (TGFβ) signaling is crucial in early tumorigenesis, particularly in breast cancer.
- While mutations in TGFβ pathway components are infrequent, the mechanisms of resistance remain largely unexplored.
- An activated Notch pathway is recognized for its role in promoting breast cancer development.
Purpose of the Study:
- To investigate the crosstalk between Notch and TGFβ signaling pathways in breast cancer.
- To elucidate the role of HEYL, a direct target of Notch signaling, in mediating this interaction.
- To understand how HEYL influences TGFβ activity and mammary gland development.
Main Methods:
- Analysis of HEYL expression in breast cancer.
- Investigating HEYL's mechanism of repressing TGFβ activity by interacting with Smads.
- Phenotypic analysis of mammary gland development in HeyL knockout and transgenic mouse models.
Main Results:
- HEYL is overexpressed in breast cancer and acts as a direct target of Notch signaling.
- HEYL represses TGFβ signaling by binding to TGFβ-activated Smads.
- HeyL knockout mice exhibit impaired mammary gland development.
- HeyL transgenic mice display accelerated mammary epithelial proliferation, with a significant incidence of mammary cancer in multiparous individuals.
Conclusions:
- Notch signaling, via HEYL, represses TGFβ activity, suggesting a novel mechanism for resistance to TGFβ.
- The Notch-HEYL-TGFβ axis plays a critical role in promoting mammary gland epithelial proliferation and may contribute to breast cancer initiation.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch Signaling Pathway
TGF - β Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Hedgehog Signaling Pathway

